Results 1 to 10 of about 172,793 (249)

Substandard and Falsified Medicines in Myanmar [PDF]

open access: yesPharmacy (Basel, Switzerland), 2020
Background: substandard and falsified medicines (SFMs) are a threat to public health. The availability of SFMs in Myanmar was reported by the World Health Organization (WHO) in 1999, but there have been few systematic surveys on falsified medicines in ...
Naoko Yoshida   +2 more
exaly   +7 more sources

Substandard and falsified medicines in Africa: healthcare systems challenges, supply chain issues, regulatory challenges and strategies to increase access to quality medicines [PDF]

open access: yesFrontiers in Pharmacology
Africa is a unique continent due to high disease burden for both communicable and non-communicable diseases, attracting large-scale distribution of medicines to tackle public health issues.
Sangeeta Tanna   +2 more
exaly   +5 more sources

Falsified Medicines—Bridging the Gap between Business and Public Health [PDF]

open access: yesPharmacy (Basel, Switzerland), 2016
The pharmaceutical industry is one of the most regulated industries in the world. While legislation is necessary to protect patients, too much legislation is said to hamper innovation and increase medicine prices.
Rasmus Borup
exaly   +5 more sources

The impact of global falsified medicines regulation on healthcare stakeholders in the legitimate pharmaceutical supply chain: a systematic review [PDF]

open access: yesFrontiers in Medicine
BackgroundFalsified medicines and their international regulation impacts all healthcare sectors and their actors. These regulations aim to strengthen and protect the global pharmaceutical supply chain against falsified medicines.
Bernard Naughton
exaly   +4 more sources

Falsified Medicines Directive: Are We Heading in the Right Direction? [PDF]

open access: yesMedicine Access @ Point of Care, 2017
Falsified medicines for human use are an increasing problem in Europe. The Falsified Medicines Directive (FMD) 2011/62/EU provides measures to prevent the entry of falsified medicines into the legal supply chain by requiring the placing of safety ...
Roberto Frontini
doaj   +4 more sources

A Cross-Sectional Investigation for Verification of Globalization of Falsified Medicines in Cambodia, Indicated by Tablets of Sildenafil Citrate [PDF]

open access: yesPharmacy (Basel, Switzerland), 2019
Medicine falsification is a global issue. Viagra, an erectile dysfunction therapeutic (EDT) medicine consisting primarily of sildenafil citrate, is the most commonly falsified medicine worldwide.
Naoko Yoshida   +2 more
exaly   +4 more sources

Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature [PDF]

open access: yesTravel Medicine and Infectious Disease
Background: The increasing prevalence of falsified and counterfeit medicines globally poses risks to international travellers. This narrative literature review examines the global challenge of falsified and counterfeit medicines, with a specific focus on
Gérard Flaherty
exaly   +4 more sources

Current challenges in the detection and analysis of falsified medicines

open access: yesJournal of Pharmaceutical and Biomedical Analysis, 2021
Falsified medicines affect public health all around the globe. Complex distribution routes, illegal online webshops and reuse of packaging materials make them hard to detect. In order to tackle this problem, detection methods for the recognition of suspicious medicines and subsequent confirmation of falsification by analytical techniques is required ...
Bastiaan Venhuis   +1 more
exaly   +5 more sources

Falsified and substandard medicines trafficking: A wakeup call for the African continent

open access: yesPublic Health in Practice, 2022
While great effort is being placed on reducing disease burdens in Africa, the circulation of falsified and substandard medicines in the continent are reversing the hard-won gains.
Yusuf Hassan Wada, Garba M Khalid
exaly   +3 more sources

Substandard and falsified medicine screening technologies [PDF]

open access: yesAAPS Open, 2019
Substandard and falsified medicine screening technologies are invaluable tools for post-marketing surveillance of medicine quality, particularly in low- and middle-income countries.
Lukas Roth   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy